Tag: T2D
GLP1R-targeting drugs dominate type 2 diabetes pipeline, reveals GlobalData
This indicates a shift from the conventional IR to the GLP1R as the primary target for pioneering T2D treatments, says GlobalData, a leading data and analytics company